COVID-19 and Cancer Immunotherapy

Edited by Paolo Antonio Ascierto and Jason D. Goldman

COVID-19 has had a profound impact on the world, and the immunotherapy field offers important insights into clinical practice, immune-related pathophysiology, and other areas that have proven useful to the global healthcare community. Authored by leading voices in the immuno-oncology, infectious disease, and virology fields, this JITC series explores basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations. This series also provides a valuable resource to readers, not only as a source for hypothesis-generation for future basic and translational studies, but as initial guidance in clinical decision-making.

Check back regularly as reviews publish throughout 2021.